Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities

Front Oncol. 2023 Jan 13:12:1106762. doi: 10.3389/fonc.2022.1106762. eCollection 2022.

Abstract

Pancreatic cancer (PC) is a malignant tumor with high malignancy that is difficult to diagnose and treat. PC is a major medical problem because of its low early diagnosis rate, high surgical mortality rate, low cure rate, and expensive related testing cost. Therefore, the significance of finding new markers for PC is self-evident. Semaphorins (Semas) have been shown to affect angiogenesis and lymphangiogenesis and can also directly affect the behavior of tumor cells. The expression and related action targets of its family members on PC are summarized in this review.

Keywords: Sema3; Sema4D; mechanisms; pancreatic cancer; semaphorins.

Publication types

  • Review

Grants and funding

The work in the Liu Lab is supported by The National Natural Science Foundation of China (Grant No. 82270413, 81870307), The Natural Science Foundation of Guangdong Province of China (Grant No. 2022A1515011368), and The Key Projects of Department of Education of Guangdong Province of China (Grant No. 2022ZDZX2057, 2022ZXKC474). The work in the You Lab is supported by The National Natural Science Foundation of China (Grant No. 81911530169).